0000919574-18-003135.txt : 20180420
0000919574-18-003135.hdr.sgml : 20180420
20180420173853
ACCESSION NUMBER: 0000919574-18-003135
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180418
FILED AS OF DATE: 20180420
DATE AS OF CHANGE: 20180420
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Boyd Steven
CENTRAL INDEX KEY: 0001706140
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36672
FILM NUMBER: 18767632
MAIL ADDRESS:
STREET 1: 510 MADISON AVENUE
STREET 2: FL 22
CITY: NEW YORK
STATE: NY
ZIP: 10022
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ARMISTICE CAPITAL, LLC
CENTRAL INDEX KEY: 0001601086
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36672
FILM NUMBER: 18767631
BUSINESS ADDRESS:
STREET 1: 510 MADISON AVENUE, 22ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (212) 231-4932
MAIL ADDRESS:
STREET 1: 510 MADISON AVENUE, 22ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Armistice Capital Master Fund Ltd.
CENTRAL INDEX KEY: 0001633584
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36672
FILM NUMBER: 18767630
BUSINESS ADDRESS:
STREET 1: C/O ARMISTICE CAPITAL, LLC
STREET 2: 510 MADISON AVENUE, 22ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-231-4932
MAIL ADDRESS:
STREET 1: C/O ARMISTICE CAPITAL, LLC
STREET 2: 510 MADISON AVENUE, 22ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EYEGATE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001372514
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 271 WAVERLEY OAKS ROAD
STREET 2: SUITE 108
CITY: WALTHAM
STATE: MA
ZIP: 02452
BUSINESS PHONE: 781-788-9043
MAIL ADDRESS:
STREET 1: 271 WAVERLEY OAKS ROAD
STREET 2: SUITE 108
CITY: WALTHAM
STATE: MA
ZIP: 02452
4
1
p7873137.xml
OWNERSHIP DOCUMENT
X0306
4
2018-04-18
0
0001372514
EYEGATE PHARMACEUTICALS INC
EYEG
0001601086
ARMISTICE CAPITAL, LLC
510 MADISON AVENUE
22ND FLOOR
NEW YORK
NY
10022
0
0
1
0
0001633584
Armistice Capital Master Fund Ltd.
C/O DMS CORPORATE SERVICES LTD.
20 GENESIS CLOSE, P.O. BOX 314
GRAND CAYMAN
E9
KY1-1104
CAYMAN ISLANDS
0
0
1
0
0001706140
Boyd Steven
C/O ARMISTICE CAPITAL, LLC
510 MADISON AVENUE, 22ND FLOOR
NEW YORK
NY
10022
0
0
1
0
Common Stock
2018-04-18
4
P
0
781254
0.4738
A
14493754
D
Common Stock
2018-04-18
4
P
0
0
0
A
14493754
I
See Footnote
Common Stock
2018-04-18
4
P
0
0
0
A
14493754
I
See Footnote
Common Stock
2018-04-19
4
P
0
1256920
0.4768
A
15750674
D
Common Stock
2018-04-19
4
P
0
0
0
A
15750674
I
See Footnote
Common Stock
2018-04-19
4
P
0
0
0
A
15750674
I
See Footnote
Common Stock
2018-04-20
4
P
0
496304
0.5273
A
16246978
D
Common Stock
2018-04-20
4
P
0
0
0
A
16246978
I
See Footnote
Common Stock
2018-04-20
4
P
0
0
0
A
16246978
I
See Footnote
The reported securities are directly owned by Armistice Capital Master Fund, Ltd.
The reported securities are directly owned by Armistice Capital Master Fund, Ltd., a Cayman Islands corporation, and may be deemed to be indirectly beneficially owned by Armistice Capital, LLC, as the investment manager of Armistice Capital Master Fund, Ltd. The reported securities may also be deemed to be indirectly beneficially owned by Steven Boyd as Managing Member of Armistice Capital, LLC and Director of Armistice Capital Master Fund, Ltd. Armistice Capital, LLC and Steven Boyd disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interest therein, and this report shall not be deemed an admission that either of them are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
This constitutes the weighted average purchase price. The prices range from $0.4541 to $0.4868. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
This constitutes the weighted average purchase price. The prices range from $0.4731 to $0.4956. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
This constitutes the weighted average purchase price. The prices range from $0.4872 to $0.5387. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Armistice Capital, LLC, By: /s/ Steven Boyd, Managing Member
2018-04-20
Armistice Capital Master Fund, Ltd., By: /s/ Steven Boyd, Director
2018-04-20
By: /s/ Steven Boyd
2018-04-20